28 May 10
Just five years after its formation through the merger of Fujisawa and Yamanouchi, Astellas has become one of the top 20 pharmaceutical companies in the world. Employing 15,000 people and with annual sales reaching âŹ1,287 million in Europe, Astellas has exceeded all expectations for growth in the past five years and the companyâs management team has devised a clear vision to ensure that this success continues in the years to come.
20 May 10
Economic uncertainty has fueled a growing trend toward self-employment and entrepreneurialism with one-in-five respondents worldwide now working outside the traditional employment relationship, and 50 percent saying that they would like to do so, according to the latest survey results from workforce solutions leader Kelly ServicesÂŽ.
13 May 10
Researchers at Weill Cornell Medical Center in New York have demonstrated that a reovirus therapy called REOLYSIN works synergistically with gemcitabine and may be worth further investigation.
23 Apr 10
The theme for National Stop Snoring Week 2010 is all about our houses. From house dust mites to pet dogs it seems that our houses are minefields when it comes to snoring. Nobody is safe as there are dangers lurking in every room.
Marianne Davey - The British Snoring & Sleep Apnoea Association (BSSAA)
22 Apr 10
Karolinska Institutet is one of the worldÂ´s leading medical universities. Its mission is to contribute to the improvement of human health through research and education. Karolinska Institutet accounts for over 40 per cent of the medical academic research conducted in Sweden and offers the countryÂ´s broadest range of education in medicine and health sciences. Since 1901 the Nobel Assembly at Karolinska Institutet selects the Nobel laureates in Physiology or Medicine.
Alex Heeley - De Facto Communications
14 Apr 10
Parents of babies and young children suffering from conditions such as asthma and eczema will be relieved to know there is a breakthrough product available that can drastically reduce their childâs misery and symptoms.
13 Apr 10
The NGP union, held in the Netherlands last week saw over 50 visionaries gathered for the Supreme Court verdict against Myriad Genetics given on March 29th. They voted against their patent claims and a storm is brewing in the biotech community. The Court ruled that the patents should have never been granted because genes are a law of nature. With the majority of industry outsiders in agreement, how will the pharmaceutical world react?
13 Apr 10
Since the moment of the NHSâs very inception in 1948, complementary medicine has formed an accepted and often-used element of the countryâs national health service. Thousands of Brits swear blind by the efficacy of homeopathic treatments and rates of patient satisfaction are often far higher at the countryâs homeopathic hospitals than they are on standard NHS wards. Yet while many patients claim a strong appreciation of the benefits of homeopathy, the science tells another story.
09 Apr 10
Until recently, pharmaceutical companies paid little attention to the process of maximising their data through publications. Today, several pharma firm and even consumer companies are beginning to recognise publications planning as an integral part of the marketing matrix. It now forms part of the overall communications strategy, adopted not only to raise awareness of a product and its key messages, but also to provide an evidence base for all other communication activities for the product.
Dr Sabah Al-Lawati
07 Apr 10
We often use them to make decisions about what products we buy and which we keep buyingâŚexcept for pharmaâ. Yet more than that, he makes a coherent and convincing argument for how these kinds of services could ultimately end up benefiting the pharma industry itself. Indeed while information from a single person on the internet might be far too subjective to be of use, the sophistication of the crowd is arguably much greater.
29 Mar 10
Urgent meetings are being held by the financial leaders of American Healthcare companies in the wake of Obamaâs Healthcare Reform being passed 219 â 212 in the House of Representatives.
18 Mar 10
Jorge Puente, Regional President of WW Pfizer gives MeetTheBoss.tv an inside look into how Pfizer became global.
Daniel Reinhold - meettheboss.tv
16 Mar 10
Back in December it was all but a question of time. More or less every pundit was concerned with âwhenâ and not âifâ and an increasingly divided nation was finally bracing itself for the very real possibility of comprehensive healthcare reform. The debate had been more or less exhausted and the Republican strategy continued along the lines of obstructionism pure and simple.
Max Golby - PharmiWeb Field Reporter
17 Feb 10
Research and development is the bread and butter of healthcare innovation. For decades the worldâs pharmaceutical companies have treasured and protected this simple maxim, pouring billions of dollars into research and development and creating hundreds of groundbreaking new drugs in the process. Yet since the onset of the global financial crisis in 2007, big pharma has begun to ask some very difficult questions of its research commitments.
12 Feb 10
Assessing the use of Point Of Care Testing in Clinical Trials - the policies and procedures involved, the benefits Point Of Care can bring to clinical trials and the advantages over the conventional laboratory approach.
Mike Wickham, Dave McComas and Charlotte Wickham
10 Feb 10
Diabetes mellitus â more commonly known as just diabetes â is a chronic metabolic condition that occurs as a result of either the pancreasâ failure to produce normal insulin levels, or as a result of the bodyâs inability to make use of the insulin that it does produce.
10 Feb 10
A recent research study, which was undertaken as part of medical research charity, Kidney Research UKâs ABLE programme, investigated the impact of national guidelines for the management of Chronic Kidney Disease (CKD), on referral patterns between South Asian and white European patients with type 2 diabetes mellitus (T2DM).
Kidney Research UK
27 Jan 10
RSS is a much under-estimated and under-used thing. It was originally conceived as an easy way of syndicating website content, hence the name âReally Simple Syndicationâ, but it now become a standard by which content is made available across the web to other sites or users.
27 Jan 10
At 16:53 local time on Tuesday, 12 January 2010, the small Caribbean island nation of Haiti was dealt another cruel blow: a massive 7.0-magnitude earthquake struck at the heart of the nation - just over 15 miles west of the capital of Port-au-Prince. With the already traumatic history of this poor yet historic nation in mind, the events of January 12 represented yet another devastating hit to the already fragile foundations of this young nation.
21 Jan 10
Hardly a week goes by without Alzheimerâs being in the news â scientists discovering more about what causes it, developing a greater idea of how we can prevent or treat it, or another step being taken towards a cure.
Jackie Cosh, author of Alzheimerâs â The Essential Guide
14 Jan 10
Washington is famous for its lobbyists. Make no mistake, of all the industries currently making themselves heard on Capitol Hill, the healthcare lobby is one of the largest and the loudest. Indeed, according to the Center for Responsive Politics, the pharmaceutical industry had almost 1700 registered lobbyists in Washington as of late 2009. Unsurprisingly, then, the pharmaceutical industry has a considerable degree of pull on The Hill.
16 Dec 09
For over 75 years now, numerous Democratic Congressmen â and indeed several Presidents â have tried to pass something remotely resembling meaningful healthcare reform. For 75 years, they have failed. Back in 1993, Bill and Hillary Clintonâs failed âHillaryCareâ died with a whimper in the Senate and Mrs. Clinton was denied her chance at a second attempt by Mr. Obama in the Democratic primaries.
08 Dec 09
âYou really need some more experienceâ. Perhaps the most ubiquitous phrase in modern day recruitment, thousands of graduates are now at the mercy of this one requirement as increasing competition in the job market leads to rising standards. Perhaps twenty, or even ten years ago, an undergraduate degree and a forceful sense of charisma might well have been enough to net you your first role in an industry.
08 Dec 09
Keynes called it an âinducement to investâ. In this instance, the most recent financial crisis has called for many of the same approaches used in the 1930s to stimulate the economy and bring industries back to their feet. Today more than ever, we realize that education is one of the most decisive facets of any successful stimulus.